Leerink Partners Reviews
Boston, MA · Founded 1995
- Type
- Industry specialist
- HQ
- Boston, MA
- Founded
- 1995
- Deal size
- $25M-$1B
- Focus
- Healthcare, Biotech
- Website
- leerink.com
- Jeff LeerinkFounder, CEO
Leerink Partners is a industry specialist headquartered in Boston, MA and founded in 1995. The firm focuses on Healthcare, Biotech and typically advises on transactions in the $25M-$1B range. Key dealmakers include Jeff Leerink (Founder, CEO). Read founder-verified reviews of Leerink Partners below, from founders who hired the firm as their sell-side advisor whether the deal closed or not.
What to know about Leerink Partners
Leerink Partners has built its franchise in Healthcare, Biotech, where founders running a sale process often turn to firms with deep sector pattern recognition. The senior bench, anchored by Jeff Leerink, sets the tone for how engagements run from the first call through whatever outcome the process produces. Founders evaluating Leerink Partners typically compare it against other industry specialist houses with similar sector emphasis.
Deal sweet spot at Leerink Partners sits in the $25M-$1B band. That target range shapes everything: which buyers get the call, how the process is paced, and how the firm allocates senior banker attention. Founders working with Leerink Partners should expect a process tuned to that band; founders far below or above it sometimes find a better fit elsewhere.
Geography matters more than founders expect. Leerink Partners operates out of Boston, MA, and its strongest buyer-side relationships tend to cluster around that orbit. For sellers running a global process, that can be either an advantage (concentrated relationships) or a constraint (thinner reach in other regions). Founders should ask directly: which buyers have you placed with in the last 24 months, and where are they.
Reviews
Reviews unlock once 5 verified founders have rated this firm. Be the first to break the silence.
Frequently asked questions
- Who can review Leerink Partners?
- Any founder who hired Leerink Partners as their sell-side advisor and ran an M&A process with them, regardless of whether the deal ultimately closed. How a banker behaves when a deal does not close is just as important as when it does, and both outcomes are welcome.
- Has Leerink Partners been reviewed by founders?
- Leerink Partners appears in the BankerNotes directory. Reviews from verified founders who hired the firm unlock publicly once five founders have submitted ratings. Until that threshold is reached, reviews are pending and not displayed.
- Where is Leerink Partners headquartered?
- Leerink Partners is headquartered in Boston, MA. The firm was founded in 1995.
- What kinds of deals does Leerink Partners work on?
- Leerink Partners focuses on Healthcare, Biotech. Typical transaction size falls in the $25M-$1B range.
- Who are the key dealmakers at Leerink Partners?
- Senior dealmakers include Jeff Leerink (Founder, CEO). Founders running a process should expect to interact most with the named partner or managing director assigned to the deal.
- How does BankerNotes verify reviews of Leerink Partners?
- Every review on BankerNotes is submitted by a founder who confirms they hired the firm as their sell-side advisor. We verify the reviewer privately using work email, LinkedIn, and approximate engagement timing. The verified identity is never published. Only the rating, written review, and a generic sector label appear on the public page.
Other Healthcare M&A advisors founders compare with Leerink Partners
More context for Leerink Partners
Last updated: July 6, 2025